kabutan

Kringle Pharma, The Current Fiscal Year's Net Income to Widen

Wed Nov 12, 2025 3:40 pm JST Earnings

4884 Kringle Pharma,Inc. 【J-GAAP】

Earnings Report

Kringle Pharma,Inc. <4884> [TSE Growth] announced its financial results after the market closed on November 12th (15:40). The net loss (non-consolidated) for the fiscal year ended September 2025 expanded to a loss of 0.91 billion yen (compared to a loss of 0.75 billion yen in the previous period). For the fiscal year ending September 2026, the net loss is expected to be loss of 1.17 billion yen. This will mark the tenth consecutive term of losses.

In the most recent three-month period, from July to September (4Q), the net loss improved to a deficit of 0.17 billion yen (compared to a loss of 0.23 billion yen in the same period last year). The operating profit/loss margin improved from -1252.6% in the same period last year to -900.0%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2023 69 -888 -852 -854 -158.5 0 Nov 13, 2023 J-GAAP
Sep, 2024 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
Sep, 2025 72 -909 -914 -916 -133.9 0 Nov 12, 2025 J-GAAP
YoY -10.0% -11.3% -21.2% -21.2% -13.3%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2025 Guidance 71 -939 -945 -946 -135.2 0 Jul 16, 2025 J-GAAP
Sep, 2025 Results 72 -909 -914 -916 -133.9 0 Nov 12, 2025 J-GAAP
Revision Rate +1.4% +3.2% +3.3% +3.2% +0.9%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 35 -511 -511 -512 -75.2 0 May 12, 2025 J-GAAP
Oct - Mar, 2025 Guidance ー ー ー ー － 0 Nov 12, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
Sep, 2025 72 -909 -914 -916 -133.9 0 Nov 12, 2025 J-GAAP
Sep, 2026 Guidance 72 -1,172 -1,172 -1,173 -163.2 0 Nov 12, 2025 J-GAAP
YoY 0.0% -28.9% -28.2% -28.1% -21.9%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 19 -238 -237 -238 -37.2 -1,252.6 Nov 13, 2024 J-GAAP
Oct - Dec, 2024 18 -212 -212 -212 -31.2 -1,177.8 Feb 7, 2025 J-GAAP
Jan - Mar, 2025 17 -299 -299 -300 -44.0 -1,758.8 May 12, 2025 J-GAAP
Apr - Jun, 2025 18 -227 -227 -227 -33.3 -1,261.1 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 19 -171 -176 -177 -25.9 -900.0 Nov 12, 2025 J-GAAP
YoY 0.0% +28.2% +25.7% +25.6% +30.4%

Related Articles